Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

Core One Labs Inc. is a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy.  The Company has developed a patent pending thin film oral strip (the “technology”) which dissolves instantly when placed in the mouth and delivers organic molecules in precise quantities to the bloodstream, maintaining excellent bioavailability. With this technology, the Company intends to further develop its IP technology to focus on delivering psychedelic molecules with an initial focus on psilocybin. Core One also holds an interest in walk-in medical clinics which maintain a database of over 200,000 patients combined. Through research and development in these clinics, including the integration of its intellectual property related to psychedelic treatments and novel drug therapies, the Company intends to work towards regulatory approval for research that advances psychedelic-derived treatments for mental health disorders.

Craftport Cannabis is a licensed producer of medical dried cannabis at its facility in Peachland, British Columbia. Through its 100-per-cent-owned subsidiary, Potanicals Green Growers Inc. ("Potanicals"), Craftport Cannabis received a production and cultivation license in October 2017 and a sales license from Health Canada in July 2019. The Health Canada sales license allows Craftport Cannabis to supply and sell finished cannabis products to provincial governments throughout Canada and through Canada's distribution and retail supply chain. Craftport Cannabis is providing recreational and medical dried cannabis, and will be providing capsules and other forms of cannabis products . As part of its expansion strategy Craftport Cannabis through its wholly-owned subsidiary and licensed producer Potanicals , has received its second cultivation license, effectively November 29, 2019, from Health Canada for the Company's joint venture greenhouse operations located in Pitt Meadows, BC.

 

 

Cresco Labs is one of the largest vertically-integrated multi-state cannabis operators in the United States. Cresco Labs is built to become the most important company in the cannabis industry by combining the most strategic geographic footprint with one of the leading distribution platforms in North America. Employing a consumer-packaged goods (“CPG”) approach to cannabis, Cresco Labs’ house of brands is designed to meet the needs of all consumer segments and includes some of the most recognized and trusted national brands including Cresco, Remedi and Mindy’s, a line of edibles created by James Beard Award-winning chef Mindy Segal. Sunnyside*, Cresco Labs’ national dispensary brand, is a wellness-focused retailer designed to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs has launched the industry’s first national comprehensive Social Equity and Educational Development (SEED) initiative designed to ensure that all members of society have the skills, knowledge and opportunity to work in and own businesses in the cannabis industry.

(Note: In addition to the 323,426,512 Subordinate Voting Shares that are issued and outstanding, there are 113,649,377 Subordinate Voting Shares reserved for issuance pursuant to the redemption and conversion rights attached to: (i) the outstanding Proportionate Voting Shares of Cresco Labs Inc. that are not listed, and (ii) certain outstanding securities of Cresco Labs, LLC, which is a subsidiary of Cresco Labs, Inc. The total number of equity shares assuming all are converted into the listed class would be 437,075,889.)

Defence Therapeutics Inc. is a biotechnology company engaged in the business of research and development, focusing on enhancing delivery of tumor-/ and infectious disease-specific therapeutics. The principal business carried on is the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases.

Delota Corp. is an established vape and cannabis retailer that curates and sells vape and nicotine-related products, other smoking cessation products, cannabis products, and accessories where regulations permit. The Company currently operates 28 brick-and-mortar specialty vape stores in Ontario under the 180 Smoke Vape Store banner name, a leading Canada-wide specialty vape e-commerce platform (www.180smoke.ca), and five licenced dispensaries under the Offside Cannabis banner name in Ontario.

Digicann Ventures Inc. is a company focused on opportunities within and outside of the cannabis industry.

Empatho Holdings Inc. is a virtual well-being firm focused on a smart solution powered by proprietary PsychAI™ artificial intelligence (AI), that strategically guides users to achieve well-being goals. Empatho provides a data-driven mobile application using advanced technology to engage individuals in the management of their own health, helping individuals become more productive and uncovering potential efficiencies and cost savings for employers.

Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders. 

FinCanna Capital Corp. (the “Issuer”) has not met the continued listing requirements as set out in CSE Policy 2, Appendix A, section 2A.6.

Pursuant to Policy 3 section 3.5(2), the Issuer may not rely on confidential price protection, nor may the Issuer complete any financing without prior Exchange approval.

In accordance with Policy 3, section 3.5, the .X extension is added to the listed securities of Issuers that the Exchange has deemed to be inactive.

Contact The Team

How can we help you?

Contact the CSE team to find out more.